Catalyst Biosciences
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Catalyst Biosciences generated cash of -$33,096,000, which is more than the previous year. Cash used in financing activities reached the amount of -$45,011,000 last year. Net change in cash is therefore -$22,681,000.

Cash Flow

Catalyst Biosciences, Inc. (NASDAQ:CBIO): Cash Flow
2013 -40.61M 13.40M -552K
2014 -34.48M 33.85M 5.00M
2015 -19.11M 37.35M 9.31M
2016 -18.47M -1.30M 948K
2017 -19.94M -11.25M 35.4M
2018 -28.55M -71.32M 111.33M
2019 -43.61M 27.39M 327K
2020 -55.04M 9.66M 60.37M
2021 -83.75M 48.18M 49.55M
2022 -33.09M 55.42M -45.01M

CBIO Cash Flow Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Cash at beginning of period
44.34M30.36M15.36M31.26M19.80M10.26M29.09M1.54M54.48M82.24M
Operating activities
Net income
-8.24M-87.93M-56.24M-55.17M-30.05M-21.56M-16.94M-14.76M-32.62M-46.70M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
230K290K138K146K149K173K389K470K351K547K
Stock-based compensation expense
1.34M3.40M3.62M3.20M2.60M863K635K326K3.47M5.21M
Deferred income tax benefit 1.34M3.40M3.62M3.20M2.60M863K635K326K3.47M5.21M
Changes in operating assets and liabilities:
Accounts receivable, net
1.61M1.49M11.68M-15M07K461K-79K1K0
Inventories
03.88M-3.04M-490K0-479K956K-1.35M00
Accounts payable
-6.22M500K1.65M3.03M500K-90K-102K-4.27M01.98M
Cash generated by operating activities
-33.09M-83.75M-55.04M-43.61M-28.55M-19.94M-18.47M-19.11M-34.48M-40.61M
Investing activities
Purchases Of Investments
00-97.63M-129.97M-198.91M-25.47M-13.40M0-7.16M-57.55M
Investments In Property Plant And Equipment
0-839K-267K-64K-376K-23K-468K-272K-4K-92K
Acquisitions Net
00-9.93M-27.45M00890K23.93M00
Cash generated by investing activities
55.42M48.18M9.66M27.39M-71.32M-11.25M-1.30M37.35M33.85M13.40M
Financing activities
Common Stock Issued
20K49.25M59.94M0106.76M15.02M958K7.25M0299K
Payments for dividends
-45.03M000000000
Repurchases of common stock
0000000-82K00
Repayments of term debt
0000-5.08M0-14.34M00-851K
Cash used in financing activities
-45.01M49.55M60.37M327K111.33M35.4M948K9.31M5.00M-552K
Net Change In Cash
-22.68M13.98M14.99M-15.89M11.45M4.20M-18.83M27.55M1.94M-27.75M
Cash at end of period
21.66M44.34M30.36M15.36M31.26M14.47M10.26M29.09M56.43M54.48M
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source